Overcoming obstacles to repurposing for neurodegenerative disease

Repurposing Food and Drug Administration (FDA)-approved drugs for a new indication may offer an accelerated pathway for new treatments to patients but is also fraught with significant commercial, regulatory, and reimbursement challenges. The Alzheimer’s Drug Discovery Foundation (ADDF) and the Micha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shineman, Diana W, Alam, John, Anderson, Margaret, Black, Sandra E, Carman, Aaron J, Cummings, Jeffrey L, Dacks, Penny A, Dudley, Joel T, Frail, Donald E, Green, Allan, Lane, Rachel F, Lappin, Debra, Simuni, Tanya, Stefanacci, Richard G, Sherer, Todd, Fillit, Howard M
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2014
Matèries:
Point of View
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4184781/
https://ncbi.nlm.nih.gov/pubmed/25356422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.76
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars